Inventor
SCANNON PATRICK J
US30 patents
⚠️ This page may combine multiple inventors who share the name “SCANNON PATRICK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XOMA CORP
16 patentsUS4925922AMay 15, 1990
Potentiation of cytotoxic conjugates
XOMA CORP135 citations96
US4916213AApr 10, 1990
Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof
XOMA CORP103 citations94
US4590071AMay 20, 1986
Human melanoma specific immunotoxins
XOMA CORP79 citations93
US5756464AMay 26, 1998
Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
XOMA CORP21 citations92
US5686414ANov 11, 1997
Methods of treating conditions associated with corneal transplantation
XOMA CORP32 citations92
US4664913AMay 12, 1987
Method for treating plasma for transfusion
XOMA CORP56 citations90
US5627153AMay 6, 1997
Anti-fungal methods and materials
XOMA CORP28 citations89
US5753620AMay 19, 1998
Human therapeutic uses of BPI protein products
XOMA CORP13 citations80
US5945399AAug 31, 1999
Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
XOMA CORP5 citations73
US5990086ANov 23, 1999
Therapeutic uses of BPI protein products for human meningococcemia
XOMA CORP6 citations72
US6191112B1Feb 20, 2001
Human therapeutic uses of BPI protein products
XOMA CORP3 citations71
US5952302ASep 14, 1999
Human therapeutic uses of BPI protein products
XOMA CORP6 citations71
US6596691B2Jul 22, 2003
Therapeutic uses of BPI protein products for human meningococcemia
XOMA CORP2 citations61
US6242418B1Jun 5, 2001
Therapeutic uses of BPI protein products for human meningococcemia
XOMA CORP2 citations61
US6586400B2Jul 1, 2003
Human therapeutic uses of BPI protein products
XOMA CORP1 citations60
US10106974B2Oct 23, 2018
Flexible manufacturing system
XOMA CORP0 citations48
XOMA TECHNOLOGY LTD
3 patentsUS8584349B2Nov 19, 2013
Flexible manufacturing system
XOMA TECHNOLOGY LTD41 citations92
US7695718B2Apr 13, 2010
Methods for the treatment of IL-1β related diseases
XOMA TECHNOLOGY LTD19 citations91
US8377429B2Feb 19, 2013
Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereof
XOMA TECHNOLOGY LTD5 citations72